The Daily Star’s FREE newsletter is spectacular! Sign up today for the best stories straight to your inbox
An elderly resident in a Swiss care home has died after receiving the Pfizer/BioNTech coronavirus vaccine.
The man was vaccinated on Christmas Eve along with other members of the nursing home in Lucerne.
Two days later he began complaining of urethral and abdominal pain and his blood pressure dropped while his heart rate increased.
He had previously reacted negatively to a flu vaccination but this had not been communicated to the vaccination team, Zeitpunkt reports.
The care home doctor examined the patient on the evening of December 27, and reported that the man was calm but his abdomen was hard and painful when touched.
Daily Star's newsletter brings you the biggest and best stories – sign up today
On Tuesday morning the doctor was informed the patient's condition had worsened.
By the time he was recalled to the home the man had died.
The patient had dementia but was reportedly otherwise healthy.
There is not yet enough evidence to suggest whether he died as a result of receiving the vaccine, and an autopsy will be performed to find out.
The Daily Star has contacted Pfizer for comment.
It's the first known case in the world of someone dying soon after receiving the groundbreaking vaccine.
There have been multiple cases of patients suffering mild to moderate allergic reactions from the jab, and it remains to be seen if the elderly man had suffered such an immune response.
The British Heart Foundation offers advice on the Covid jab, and explains like all medicines, vaccines can cause side effects.
Most are mild and shot-lived, including pain at the injection site, a headache or tiredness, while many people will not experience any side effects.
The symptoms can be experienced with many vaccines, not just one developed for coronavirus, and people might feel unwell as their immune system responds to the protein.
More than 600,000 Brits have already received the Pfizer/BioNTech vaccine after it was rolled out at the beginning of December.
Today it was announced the Oxford/AstroZeneca has also been approved for use in the UK.
Source: Read Full Article